Bayer Cropscience Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

44.90

44.90

44.90

44.90

44.90

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

2,805.50

2,804.50

2,667.20

2,479.40

2,505.40

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

2,850.40

2,849.40

2,712.10

2,524.30

2,550.30

Uses of funds

Fixed assets

Gross block

853.90

685.90

778.40

467.50

669.80

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

384.20

271.40

316.00

-

245.10

Net block

469.70

414.50

462.40

467.50

424.70

Capital work-in-progress

118.70

118.60

109.20

98.30

76.30

Investments

35.40

53.90

41.10

38.50

52.20

Net current assets

Current assets, loans & advances

4,622.10

4,010.10

4,065.90

3,748.60

3,686.10

Less : current liabilities & provisions

2,395.50

1,747.70

1,966.50

1,828.60

1,689.00

Total net current assets

2,226.60

2,262.40

2,099.40

1,920.00

1,997.10

Miscellaneous expenses not written

-

-

-

-

-

Total

2,850.40

2,849.40

2,712.10

2,524.30

2,550.30

Notes:

Book value of unquoted investments

35.40

53.90

41.10

38.50

52.20

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

695.80

562.90

372.70

366.60

292.30

Number of equity sharesoutstanding (Lacs)

449.42

449.42

449.42

449.42

449.42